Yayınlar & Eserler

Yayın Ağı
Makaleler 14
Tümü (14)
SCI-E, SSCI, AHCI (9)
SCI-E, SSCI, AHCI, ESCI (10)
ESCI (1)
Scopus (10)
TRDizin (4)
Diğer Yayınlar (1)

1. Improving the Doxorubicin Loading to PLGA Nanoparticles with TOPSIS-Based Taguchi Design Approach: Effect of the Water Phase

Tonbul H., Ultav G.
JOURNAL OF PHARMACEUTICAL INNOVATION , cilt.19, sa.5, ss.1-8, 2024 (SCI-Expanded, Scopus) identifier

2. An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles

Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., et al.
JOURNAL OF DRUG TARGETING , cilt.32, sa.9, ss.1101-1110, 2024 (SCI-Expanded, Scopus) identifier identifier

3. Silica nanoparticle synthesis by experimental design for drug and gene delivery applications

Ultav G., TONBUL H., ŞAHİN A., ÇAPAN Y.
Journal of research in pharmacy (online) , cilt.27, sa.1, ss.12-22, 2023 (Scopus, TRDizin) Creative Commons License identifier identifier

4. Development of Silica Nanoparticles as a Delivery System for Plasmid-Based Crispr/Cas9

ULTAV G., MAÇ K., KIZILBOĞA S., GÜNDOĞDU V., TONBUL H., ŞALVA E.
Anatolian Journal of Pharmaceutical Sciences , cilt.1, sa.1, ss.33-39, 2022 (Hakemli Dergi)

5. An effective VEGF-siRNA delivery via folic acid decorated and pegylated silica nanoparticles

Ultav G., TONBUL H., ŞALVA E.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.76, 2022 (SCI-Expanded, Scopus) identifier

6. pH-sensitive chitosan-PEG-decorated hollow mesoporous silica nanoparticles could be an effective treatment for acute myeloid leukemia (AML)

Ultav G., Tonbul H., Tavukcuoglu E., Ozturk S. C., Akbas S., Sahin A., et al.
JOURNAL OF NANOPARTICLE RESEARCH , cilt.24, sa.2, 2022 (SCI-Expanded, Scopus) identifier

7. Development of curcumin and docetaxel co-loaded actively targeted PLGA nanoparticles to overcome blood brain barrier

Seko I., TONBUL H., Tavukcuoglu E., Sahin A., Akbas S., Yanik H., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.66, 2021 (SCI-Expanded, Scopus) identifier

8. Folic acid decoration of mesoporous silica nanoparticles to increase cellular uptake and cytotoxic activity of doxorubicin in human breast cancer cells

TONBUL H., Sahin A., Tavukcuoglu E., Ultav G., Akbas S., AKTAŞ Y., et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.63, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

9. Brain-targeted nanoparticles to overcome the blood-brain barrier

SEKO I., ŞAHİN A., TONBUL H., ÇAPAN Y.
Journal of Pharmaceutical Technolgy , cilt.1, sa.1, ss.26-40, 2020 (TRDizin)

10. Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer

Tonbul H., Sahin A., Tavukcuoglu E., ESENDAĞLI G., ÇAPAN Y.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY , cilt.54, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

11. Development of paclitaxel and flurbiprofen co-loaded PLGA nanoparticles: understanding critical formulation and process parameters using Plackett-Burman design

Sahin A., Caban-Toktas S., Tonbul H., Yerlikaya F., AKTAŞ Y., ÇAPAN Y.
ISTANBUL JOURNAL OF PHARMACY , cilt.49, sa.3, ss.161-166, 2019 (ESCI, TRDizin) Sürdürülebilir Kalkınma identifier

12. Demographics and clinical characteristic of patients diagnosed with hen’xxs egg allergy

Topal E., Arga M., Celiksoy M. H., Kaynak M. S., Duman Y., Demirtas S., et al.
Annals of Medical Research , cilt.25, sa.4, ss.1-4, 2019 (TRDizin)

13. Independent predictive factors for the persistence and tolerance of cow's milk allergy

TOPAL E., Celiksoy M. H., ARGA M., KAYNAK M. S., DUMAN Y., DEMIRTAS S., et al.
INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY , cilt.9, sa.1, ss.67-71, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

14. Synthesis of Small-Sized Mesoporous Silica Nanoparticles by Experimental Design and Characterization for Further Drug Delivery

TONBUL H., Ultav G., Akbas S., Sahin A., AKTAŞ Y., ÇAPAN Y.
LATIN AMERICAN JOURNAL OF PHARMACY , cilt.38, sa.11, ss.2204-2210, 2019 (SCI-Expanded, Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 22

1. Silica Nanoparticles as Drug and siRNA Delivery System

ULTAV G., TONBUL H., ŞALVA E.
3rd International Conferance on Materials Science and Nanotechnology, Roma, İtalya, 3 - 07 Ekim 2022, (Özet Bildiri)

2. In vivo Evaluation of Doxorubicin and Elacridar Co-Loaded PLGA/Silica Hybrid Nanoparticles Against Multidrug Resistant Breast Cancer

TONBUL H., ŞAHİN A., ÖZTÜRK S. C., ULTAV G., ESENDAĞLI G., ÇAPAN Y.
9 th BBBB International Conference on Pharmaceutical Sciences, Ljubljana, Slovenya, 15 - 17 Eylül 2022, (Tam Metin Bildiri)

3. Combination Therapy Approach of Doxorubicin and siRNA with Biodegradable Silica Nanoparticles

ULTAV G., TONBUL H., ŞALVA E.
The 4th International Conference on Graphene and Novel Nanomaterials (GNN 2022), Shenzhen, Çin, 8 - 11 Ağustos 2022, (Özet Bildiri)

4. DETERMINATION OF EFFECTIVE SURFACE MODIFICATIONS OF SILICA NANOPARTICLES AS VEGF-TARGETED siRNA CARRIERS

ULTAV G., TONBUL H., ŞALVA E.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Türkiye, 22 Haziran 2021, (Özet Bildiri)

5. Productıon of Meloxıcam Nanocrystals by Nanoprecıpıtatıon Method

ŞAHİN A., TONBUL H.
The Sixth International Symposium on Pharmaceutical and Biomedical Sciences - ISPBS-6, Gaziantep, Türkiye, 26 - 28 Mayıs 2022, (Özet Bildiri)

6. EVALUATION AND CHARACTERIZATION OF FOLIC ACID MODIFIED SILICA NANOPARTICLES AS SIRNA CARRIERS

ULTAV G., ŞALVA E., TONBUL H.
3rd International Gazi Pharma Symposium Series (GPSS- 2021), Türkiye, 08 Eylül 2021, (Özet Bildiri)

7. İnek sütü proteini alerjisinin devamlılığını ve toleransını öngören faktörler

TOPAL E., ÇELİKSOY M. H., ARGA M., KAYNAK M. S., DUMAN Y., DEMİRTAŞ M. S., et al.
16.Anadolu Gastroenteroloji Günleri, Şanlıurfa, Türkiye, 11 Eylül 2020, ss.123, (Tam Metin Bildiri)

8. PREPARATİON OF PLGA NANOPARTİCLES WITH DIFFERENT SURFACTANTS AS DRUG DELİVERY SYSTEM

TONBUL H., ŞAHİN A.
GEVHER NESİBE4. ULUSLARARASI SAĞLIK BİLİMLERİ KONGRESİ, Ankara, Türkiye, 22 - 23 Kasım 2019, (Tam Metin Bildiri)

9. FOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES FOR ENHANCED THERAPEUTIC EFFICACY OF DOXORUBICIN IN BREAST CANCER

TONBUL H., ULTAV G., AKBAŞ S., ŞAHİN A., TAVUKÇUOĞLU E., AKTAŞ Y., et al.
8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

10. PREPARATION OF ACTIVE TARGETED POLY(LACTİC-CO-GLYCOLİC ACİD) NANOPARTİCLES WİTH OLEYL CYSTEINEAMIDE

AKBAŞ S., ULTAV G., ŞAHİN A., TAVUKÇUOĞLU E., TONBUL H., ESENDAĞLI G., et al.
8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

11. FOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES FOR ENHANCED THERAPEUTIC EFFICACY OF DOXORUBICİN IN BREAST CANCER

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., TAVUKÇUOĞLU E., AKTAŞ Y., et al.
8th BBBB Conference on Pharmaceutical Sciences, 14 - 16 Ekim 2019, (Tam Metin Bildiri)

12. REVERSAL OF DRUG RESISTANCE IN EMT6/AR1 CELL LINE BY A CHEMİCAL MODULATOR: ELACRIDAR

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., ÇAPAN Y.
International Multidisciplinary Symposium on Drug Research and Development (DRD)-2019, 1 - 03 Temmuz 2019, (Tam Metin Bildiri)

13. , İzlemde İnek Sütü Alerjisinin Persistansı ve Tolerans Gelişimiyle İlişkili BağımsızRisk Faktörleri

TOPAL E., Çeliksoy M. H., ARGA M., Kaynak M. S., DUMAN Y., Demirtaş S., et al.
25. Ulusal Allerji ve Klinik İmmünoloji Kongresi, 17 - 21 Kasım 2018, (Tam Metin Bildiri)

14. PREPERATION, CHARACTERIZATION, CYTOTOXICITY EVALUATIONS OFFOLIC ACID CONJUGATED MESOPOROUS SILICA NANOPARTICLES

TONBUL H., ultav g., akbas s., sahin a., tavukcuoglu e., AKTAŞ Y., et al.
19th InternationalPharmaceutical Technology Symposium-IPTS 2018, 17 - 19 Eylül 2018, (Tam Metin Bildiri)

15. A COMPERISON OF PLGA NANOPARTICLE PREPARATION METHODS FOR BEVACIZUMAB ENCAPSULATION

AKBAŞ S., ULTAV G., TONBUL H., ŞAHİN A., ÇAPAN Y.
12th International Symposium on Pharmaceutical Sciences (ISOPS), 26 - 29 Haziran 2018, (Özet Bildiri)

16. IN VITRO EVALUATION OF PACLITAXEL LOADED MESOPOROUS SILICA NANOPARTICLES

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.
EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

17. DEVELOPMET AND EVALUATION OF SILICA NANOPARTICLES USING A QUALITY BY DESIGN APPROACH

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., AKTAŞ Y., ÇAPAN Y.
EUFEPS Annual Meeting 2018, 24 - 26 Mayıs 2018, (Özet Bildiri)

18. SYNTHESIS AND CHARACTERIZATION OF SILICA NANOPARTICLES: OBTAINING NANOPARTICLES SMALLER THAN 100 NM

TONBUL H., AKBAŞ S., ULTAV G., ŞAHİN A., KAYNAK M. S., AKTAŞ Y., et al.
2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

19. DEVELOPMENT AND IN VITRO EVALUATION OF PH TRIGGERED HOLLOW SILICA NANOPARTICLES AS A DRUG DELIVERY SYSTEM

ULTAV G., AKBAŞ S., TONBUL H., ŞAHİN A., ÇAPAN Y.
2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

20. CHARACTERIZATION OF BEVACIZUMAB BY DYNAMIC LIGHTSCATTERING TECHNIQUE

AKBAŞ S., ULTAV G., TONBUL H., ŞAHİN A., ÇAPAN Y.
2nd International Gazi Pharma Symposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

21. Transferrine hedeflendirilmiş paklitaksel yüklü PLGA nanopartiküllerinin meme kanserindeki etkinliği

TONBUL H., ŞAHİN A., ÖZTÜRK N., VURAL İ., KAYNAK M. S., ÇAPAN Y.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu (ANES), Türkiye, 1 Haziran - 02 Ocak 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

22. DEVELOPMENT AND IN VITRO EVALUATION OF TRANSFERRIN TARGETED PLGA NANOPARTICLES

TONBUL H., ŞAHİN A., KAYNAK M. S., ÇAPAN Y.
18th International Pharmaceutical Technology Symposium-IPTS 2016, 18 - 21 Ekim 2016, (Tam Metin Bildiri)
Kitaplar 8

1. Hybrid PLGA nanoparticles as advanced drug delivery and theranostic applications

TONBUL H., ÇAPAN Y.
Poly(lactic-co-glycolic acid) (PLGA) Nanoparticles for Drug Delivery, Prashant Kesharwani, Editör, Elsevier, ss.417-431, 2023

2. Overcoming the challenges of drug resistance through combination drug delivery approach

TONBUL H., ŞAHİN A., ÇAPAN Y.
Combination Drug Delivery Approach as an Effective Therapy for Various Diseases, Prashant Kesharwani, Editör, Academic Press , ss.31-46, 2022

3. Targeted Drug Delivery of Nanoparticles

TONBUL H., ÇAPAN Y.
Nanotechnology for Biomedical Applications, Sreerag Gopi, Preetha Balakrishnan, Nabisab Mujawar Mubarak, Editör, Springer Singapore, ss.203-217, 2022

4. Drug Delivery with Targeted Nanoparticles In Vitro and In Vivo Evaluation Methods

Çapan Y. (Editör), Şahin A. (Editör), Tonbul H. (Editör)
Jenny Stanford Publishing, Singapore, 2021

5. Characteristics of Marketed Nanopharmaceutics

ŞALVA E., TONBUL H.
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods (1st ed.), Yılmaz Çapan, Adem Sahin, Hayrettin Tonbul, Editör, Jenny Stanford Publishing, ss.705-724, 2021

6. Evaluation of Targeted Mesoporous Silica Nanoparticles

TONBUL H.
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods (1st ed.), Yılmaz Çapan, Adem Sahin, Hayrettin Tonbul, Editör, Jenny Stanford Publishing, ss.643-656, 2021

7. Regulatory Guidelines of the US Food and Drug Administration and the European Medicines Agency for Actively Targeted Nanomedicines

ÇETİNTAŞ H. C., TONBUL H., ŞAHİN A., ÇAPAN Y.
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods (1st ed.), Yılmaz Çapan, Adem Sahin, Hayrettin Tonbul, Editör, Jenny Stanford Publishing, ss.725-742, 2021

8. Characteristics of Marketed Nanopharmaceutics

ŞALVA E., TONBUL H.
Drug Delivery with Targeted Nanoparticles: In Vitro and In Vivo Evaluation Methods, Çapan, Y., Sahin, A., Tonbul, H., Editör, Jenny Stanford Publishing, ss.705-720, 2021
Metrikler

Yayın

46

Yayın (WoS)

10

Yayın (Scopus)

10

Atıf (WoS)

3

H-İndeks (WoS)

1

Atıf (Scopus)

1

H-İndeks (Scopus)

1

Atıf (Diğer Toplam)

1

Proje

7

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları